Video Experimental Relacionado

Updated: Sep 10, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Implicaciones de la vergüenza para los resultados informados por los pacientes en trastornos intestinales de

Inês A Trindade¹, Amanda Blomsten², Sanna Nybacka²

¹Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; EMBRACE Lab, Center for Health and Medical Psychology, Örebro University, Örebro, Sweden.

Gastroenterology

|August 21, 2025

Resumen

La vergüenza tiene un impacto significativo en las personas con trastornos intestinales de interacción intestino-cerebral (DGBI), empeorando la ansiedad, la depresión y la calidad de vida. Abordar la vergüenza a través de la empatía y la terapia es crucial para el manejo de los resultados de los pacientes con DGBI.

Área de la Ciencia:

Medicina psicosomática
Gastroenterología
Psicología clínica

Sus antecedentes:

Los trastornos intestinales de interacción intestino-cerebro (DGBI) están muy estigmatizados, sin embargo, el papel de la vergüenza sigue siendo poco investigado.
La literatura existente reconoce el vínculo entre el estigma y la vergüenza, pero carece de un enfoque específico en la vergüenza dentro de la DGBI intestinal.

Objetivo del estudio:

Para investigar las implicaciones de la vergüenza en los trastornos intestinales de la interacción intestino-cerebral.
Examinar cómo la vergüenza media y modera la relación entre los síntomas intestinales y los resultados psicosociales.

Principales métodos:

Estudio transversal utilizando dos muestras basadas en la población sueca: DGBI intestinal (n=537) y un grupo de control emparejado (n=1881).
Se administraron encuestas en línea con escalas de autoinforme validadas.
Se utilizó el modelado de ecuaciones estructurales para el análisis de la mediación y se realizó un análisis de la moderación.

Principales resultados:

Las personas con DGBI intestinal informaron niveles significativamente más altos de vergüenza en comparación con los controles.
La vergüenza medió la asociación entre los síntomas intestinales y la ansiedad general, los síntomas depresivos, la calidad de vida y el deterioro de la actividad.
La vergüenza exacerbó el impacto de los síntomas intestinales en la ansiedad específica gastrointestinal, los síntomas depresivos y la calidad de vida.

Conclusiones:

La vergüenza es una consecuencia emocional significativa de los síntomas gastrointestinales en la DGBI intestinal, que afecta los resultados informados por los pacientes.
Se recomienda una relación empática médico-paciente e intervenciones psicológicas para manejar la vergüenza en la DGBI intestinal.
Se justifica una mayor investigación sobre el impacto psicológico de la vergüenza en la DGBI.

Palabras clave:

DGBI para el intestino Trastornos de la interacción intestino-cerebro La angustia psicológica Calidad de vida Qué vergüenza.

Más Videos Relacionados

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

Videos de Conceptos Relacionados

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Assessment of the Gastrointestinal System I: Subjective Data

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include: